ライフサイエンスコーパス: cellulitis

1 PPSV23 (Guillain-Barre syndrome), or PPSV23 (cellulitis).

2 , patient with pacemaker and severe purulent cellulitis).

3 al and perineal wound, 30-day, purulence, or cellulitis).

4 vs. asthma; aHR 1.26, [95% CI 1.22-1.30] vs. cellulitis).

5 ons (pneumonia, urinary tract infection, and cellulitis).

6 ially treated with levofloxacin for presumed cellulitis.

7 were admitted primarily for the treatment of cellulitis.

8 n causing chronic rhinosinusitis and orbital cellulitis.

9 ts admitted for treatment of lower extremity cellulitis.

10 patients with chronic sinusitis and orbital cellulitis.

11 m the ED with a diagnosis of lower extremity cellulitis.

12 omy, biliary tract disorders, pneumonia, and cellulitis.

13 vely enrolled 216 patients hospitalized with cellulitis.

14 tions across the registry were pneumonia and cellulitis.

15 en, adults, and patients with abscess versus cellulitis.

16 eutic approaches and may progress to orbital cellulitis.

17 tion group, 2 (10%) were diagnosed as having cellulitis.

18 with placebo for the prevention of recurrent cellulitis.

19 and distinguish it from more common forms of cellulitis.

20 g CA-MRSA are beneficial in the treatment of cellulitis.

21 ation approximately as common as periorbital cellulitis.

22 enia, neutropenia, diarrhoea, pneumonia, and cellulitis.

23 st MRSA as the causative organism of orbital cellulitis.

24 hospital with the diagnosis of right orbital cellulitis.

25 nly pneumonia, congestive heart failure, and cellulitis.

26 of urinary tract infection and one extremity cellulitis.

27 nze edema, 23 had both, and 17 had recurrent cellulitis.

28 bial venous stasis ulcers, bronze edema, and cellulitis.

29 was seen in the thumb of the 1 patient with cellulitis.

30 h leg swelling thought to be consistent with cellulitis.

31 All had good interobserver agreement except cellulitis.

32 from the bloodstream of a patient with acute cellulitis.

33 rotective immunity to experimentally induced cellulitis.

34 tively included 58 patients hospitalized for cellulitis.

35 nt of endophthalmitis, orbital and preseptal cellulitis.

36 Staphylococcus aureus infections that cause cellulitis.

37 showed acute sinusitis and extensive orbital cellulitis.

38 sion via HA and conferred protection against cellulitis.

39 ith a cohort of nonnecrotizing streptococcal cellulitis.

40 y infection (ABI), pneumonia, or nonpurulent cellulitis.

41 h 30 matched retinoblastoma controls without cellulitis.

42 y to improve the management of patients with cellulitis.

43 (45.1%) of whom had a consensus diagnosis of cellulitis.

44 skin microbiota signatures in patients with cellulitis.

45 cal parameters and outcomes in patients with cellulitis.

46 ge- and sex-matched control subjects without cellulitis.

47 LCV is variable and frequently mistaken for cellulitis.

48 the cost and complications from misdiagnosed cellulitis.

49 ts admitted for treatment of lower extremity cellulitis.

50 m the ED with a diagnosis of lower extremity cellulitis.

51 The primary outcome was the recurrence of cellulitis.

52 n infection, and the presence of nonpurulent cellulitis.

53 characteristic but nondiagnostic feature of cellulitis.

54 were admitted primarily for the treatment of cellulitis.

55 hronic edema of the leg is a risk factor for cellulitis.

56 skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for

57 events (erythema 20 [27%]), pain 19 [26%]), cellulitis (14 [19%]), and oedema (nine [12%]), most of

58 The most prevalent diagnosis was orbital cellulitis (14.5%), followed by orbital floor fracture (

59 ring in >/= 2% of T-VEC-treated patients was cellulitis (2.1%).

60 uveae (39% vs. 14%; P < 0.001), and orbital cellulitis (3% vs. <1%; P = 0.05).

61 onia (8%), urinary tract infection (4%), and cellulitis (3%).

62 thrombocytopenia (9.1%), fatigue (4.5%), and cellulitis (3.6%).

63 cebo group; p = 0.02), quicker resolution of cellulitis (7 [5-20] vs 12 [5-93] days; p = 0.03), short

64 s 66.63% higher odds of being diagnosed with cellulitis (95% confidence interval [CI]: [61.2, 72.3]).

65 iabetes with ophthalmic manifestations, skin cellulitis/abscess, pyogenic arthritis, tuberculosis, lo

66 s with uncomplicated skin infections who had cellulitis, abscesses larger than 5 cm in diameter (smal

67 an estimated 14.5 million cases annually of cellulitis account for $3.7 billion in ambulatory care c

68 he lower extremity are often misdiagnosed as cellulitis (aka "pseudocellulitis") and treated with ant

69 he lower extremity are often misdiagnosed as cellulitis (aka "pseudocellulitis") and treated with ant

70 correct diagnosis for 100% of patients with cellulitis and 50% of those with pseudocellulitis.

71 abscess of finger and toe (681.XX) and other cellulitis and abscess (682.XX).

72 ith the primary diagnosis (ICD-9-CM code) of cellulitis and abscess of finger and toe (681.XX) and ot

73 nfection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-

74 ncomplicated skin infections, including both cellulitis and abscesses.

75 The case of a patient presenting with cellulitis and bacteremia secondary to R. gilardii is de

76 ture measures were observed between cases of cellulitis and cases of pseudocellulitis.

77 tions were associated with decreased LOS for cellulitis and decreased mortality for CAP.

78 , patients reported a decreased incidence of cellulitis and decreased reliance on conservative therap

79 mproves the diagnostic accuracy of suspected cellulitis and decreases unnecessary antibiotic use in p

80 ntation with distracting symptoms of scrotal cellulitis and epididymo-orchitis, as seen in our patien

81 ith primary clinical presentation as scrotal cellulitis and epididymo-orchitis.

82 investigated whether MRSA ST45 isolates from cellulitis and from osteomyelitis display distinctive ph

83 , glaucoma, and infection, including orbital cellulitis and lid abscess.

84 In humans it most commonly causes cellulitis and localized superficial skin abscesses foll

85 s among outpatients older than 12 years with cellulitis and no wound, purulent drainage, or abscess e

86 may mimic common conditions such as orbital cellulitis and optic neuritis.

87 fection (pneumonia, urinary tract infection, cellulitis and osteomyelitis, and bacteremia and sepsis)

88 fection (pneumonia, urinary tract infection, cellulitis and osteomyelitis, and bacteremia and sepsis)

89 Coexisting orbital cellulitis and panophthalmitis is a rare clinical event

90 Among patients with cellulitis and patients with patients with necrotizing f

91 otinib group were pneumonia (seven [3%]) and cellulitis and pneumothorax (four [2%], each); the most

92 timal performance for discriminating between cellulitis and pseudocellulitis.

93 tic choice is more crucial for management of cellulitis and should be guided by the prevalence of CA-

94 Study patients were adults with infective cellulitis and signs of systemic inflammation.

95 n the diagnosis and management of periocular cellulitis and to alert physicians to emerging pathogens

96 outcomes of patients with ICU-necessitating cellulitis and to compare them with patients with necrot

97 vs. asthma; aHR 1.36 [95% CI 1.31-1.41] vs. cellulitis) and VTE (aHR 1.28 [95% CI 1.24-1.33] vs. ast

98 patients, 79 (30.5%) were misdiagnosed with cellulitis, and 52 of these misdiagnosed patients were a

99 patients, 79 (30.5%) were misdiagnosed with cellulitis, and 52 of these misdiagnosed patients were a

100 ents (30.5%) had an abscess, 280 (53.4%) had cellulitis, and 82 (15.6%) had mixed infection, defined

101 skin diseases, urticaria, pruritus, scabies, cellulitis, and alopecia areata were underrepresented in

102 venous stasis disease, pretibial ulceration, cellulitis, and bronze edema.

103 rosive tracheitis, pleuropneumonia, regional cellulitis, and necrotizing lymphadenitis.

104 nal abscesses requiring surgery, one had arm cellulitis, and one had histoplasmosis.

105 include chemical injuries, orbital-preseptal cellulitis, and orbital fractures.

106 ings, improved the outcomes in patients with cellulitis, and resulted in an annual saving of approxim

107 olates in chronic rhinosinusitis and orbital cellulitis, and to look for the effects of antimicrobial

108 Adherence to the ACH cellulitis antibiotic guideline improved from 38% to 48%

109 The majority of cases of cellulitis are nonculturable and therefore the causative

110 biotics and hospitalization for misdiagnosed cellulitis are projected to cause more than 9000 nosocom

111 f an admission having a primary diagnosis of cellulitis as a function of demographics, payer, locatio

112 illin-resistant S. aureus (MRSA) in cases of cellulitis associated with specific risk factors, such a

113 Necrotizing fasciitis is often confused for cellulitis at initial presentation and is considered to

114 All recent cases of orbital cellulitis at several hospitals and surgical centers wer

115 ent-related deaths secondary to peritonitis, cellulitis at the thoracoscopy site, and empyema.

116 ed that this case has developed eosinophilic cellulitis, based on the clinical manifestation and path

117 cases of radiographically confirmed orbital cellulitis between 2004 and 2012 at Children's Hospital

118 hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012.

119 hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012.

120 ly within infected foci in osteomyelitis and cellulitis but not in successfully treated infections or

121 ny cutaneous conditions may clinically mimic cellulitis, but little research has been done to assess

122 een recommended to prevent the recurrence of cellulitis, but there is limited evidence from trials re

123 oup, all 9 patients were diagnosed as having cellulitis by PCPs, but dermatologist evaluation determi

124 ompetent adults who were diagnosed as having cellulitis by their primary care physicians (PCPs), cond

125 etween significant reductions in episodes of cellulitis (cancer vs noncancer cohorts) and outpatient

126 The bacterial cause of cellulitis cannot be determined by comparing the prevale

127 ion of postlaminar tumor invasion in orbital cellulitis cases from 32% (95% confidence interval [CI],

128 In the 15% of cellulitis cases in which organisms are identified, most

129 res of the retinoblastoma-associated orbital cellulitis cases with retinoblastoma controls.

130 djacent choroid) was solely found in orbital cellulitis cases, of which none (0/16) showed tumor inva

131 posing condition, are susceptible to orbital cellulitis caused by community-associated methicillin-re

132 A total of 15 MRSA ST45 isolates from cellulitis (CL-MRSA; n = 6) or osteomyelitis (OM-MRSA; n

133 istal normal-appearing skin of patients with cellulitis, compared with expression in the skin of cont

134 g patients with chronic edema of the leg and cellulitis, compression therapy resulted in a lower inci

135 s in the control group who had an episode of cellulitis crossed over to the compression group.

136 e, the estimated amplitude of seasonality of cellulitis decreased by approximately 71%.

137 unaffected skin showed an 87.5% accuracy in cellulitis diagnosis.

138 lue, and 83.3% negative predictive value for cellulitis diagnosis.

139 Despite the well-known tendency of cellulitis due to beta-hemolytic streptococci to recur,

140 ber needed to treat to prevent one recurrent cellulitis episode of 5 (95% CI, 4 to 9).

141 with similar reductions in adjusted rates of cellulitis episodes (from 21.1% to 4.5% in the cancer co

142 cluded wound infection in 46.8% of patients, cellulitis/erysipelas in 30.5%, and major abscess in 22.

143 ic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn's disease, obesity, cancer

144 elines do not recommend CA-MRSA coverage for cellulitis, except purulent cellulitis, which is uncommo

145 been proposed as tools to help differentiate cellulitis from pseudocellulitis.

146 skin surface temperature in differentiating cellulitis from pseudocellulitis.

147 Patients with cellulitis had more chronic comorbidities than patients

148 hs for up to 3 years or until 45 episodes of cellulitis had occurred in the trial.

149 lanned interim analysis, when 23 episodes of cellulitis had occurred, 6 participants (15%) in the com

150 ) in the control group had had an episode of cellulitis (hazard ratio, 0.23; 95% confidence interval

151 ) in the control group were hospitalized for cellulitis (hazard ratio, 0.38; 95% CI, 0.09 to 1.59).

152 Wound dehiscence, recurrent cellulitis, hematomas, neuropathies, and impaired mobili

153 poprostenol delivery system included sepsis, cellulitis, hemorrhage, and pneumothorax (4% incidence f

154 s developed in 16 patients (0.019%), orbital cellulitis in 24 patients (0.029%) and preseptal celluli

155 ulitis in 24 patients (0.029%) and preseptal cellulitis in 55 patients (0.065%).

156 methicillin-resistant S. aureus ST80 orbital cellulitis in a previously healthy neonate.

157 s paper was to analyze the causes of orbital cellulitis in connection with covert dental changes as w

158 ncephalitis, and death in farmed fish and of cellulitis in human beings.

159 We established cellulitis in mice by using a strain of group G streptoc

160 national health care burden of misdiagnosed cellulitis in patients admitted for treatment of lower e

161 national health care burden of misdiagnosed cellulitis in patients admitted for treatment of lower e

162 injections, blood pressure readings, trauma, cellulitis in the at-risk arm, and air travel and increa

163 orter mean LOS compared to participants with cellulitis in the control group (coefficient estimate =

164 Participants with cellulitis in the intervention group had significantly s

165 lt in higher rates of clinical resolution of cellulitis in the per-protocol analysis.

166 nd estimates of annual costs of misdiagnosed cellulitis in the United States.

167 nd estimates of annual costs of misdiagnosed cellulitis in the United States.

168 f a fastidious Bergeyella species from acute cellulitis in the upper extremity of a 60-year-old woman

169 with chronic edema of the leg and recurrent cellulitis, in a 1:1 ratio, to receive leg compression t

170 of an admission with a primary diagnosis of cellulitis increase with higher temperatures in a dose-r

171 xtreme temperatures, and skin infections-eg, cellulitis) increase the risk of breast cancer-related l

172 This study suggests that although cellulitis increases risk of lymphedema, ipsilateral blo

173 Cellulitis is a common and costly problem, often diagnos

174 Cellulitis is a common global health burden, with more t

175 Cellulitis is a commonly occurring skin and soft tissue

176 Cellulitis is an infection of the deep dermis and subcut

177 The diagnosis of cellulitis is based primarily on history and physical ex

178 Preseptal cellulitis is characterized by local inflammation anteri

179 d Relevance: Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessary patient

180 Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessary patient

181 Orbital cellulitis is common in young children and is often seco

182 The incidence of cellulitis is highly seasonal and this seasonality may b

183 Cellulitis is misdiagnosed in up to 30% of cases due to

184 al-appearing skin of patients with infective cellulitis is unknown.

185 complication rate, including bleeding, minor cellulitis, leakage, and blockage, was 52%.

186 fined as at least one abscess lesion and one cellulitis lesion.

187 cases best correspond to a widespread giant cellulitis-like form of Sweet syndrome.

188 o intravenous antibiotic therapy for orbital cellulitis may hasten resolution of inflammation with a

189 istal normal-appearing skin of patients with cellulitis (mean ratios, 201.1 vs. 11.65; P=.0103).

190 Overall, the composition of the cellulitis microbiota could not be distinguished from th

191 ulitis, we were unable to identify a typical cellulitis microbiota.

192 Encompassing a myriad of cellulitis-mimicking oncologic adverse cutaneous drug re

193 term pseudocellulitis or showed evidence of cellulitis mimicry.

194 We estimate cellulitis misdiagnosis leads to 50000 to 130000 unneces

195 ever; unspecified allergy; syncope/collapse; cellulitis; myalgia; and dizziness/giddiness.

196 Procedure-related complications included: cellulitis (n = 1), esophagitis (n = 1), aspiration pneu

197 abscess/wound (n = 3), mastoiditis (n = 2), cellulitis (n = 2), peritonitis (n = 1), septic arthriti

198 Overall, 54 patients with cellulitis (n = 23; mean [SD] age, 57.2 [17.7] years) or

199 d hypertension (n = 7), neutropenia (n = 5), cellulitis (n = 3), and headache (n = 2).

200 dominal pain (n=1 [2%]), syncope (n=1 [2%]), cellulitis (n=1 [2%]), pneumonitis (n=1 [2%]), headache

201 ), pneumonia (n=7 [7%]), pyrexia (n=4 [4%]), cellulitis (n=3 [3%]), fall (n=3 [3%]), and sepsis (n=3

202 st common being neutropenia (n=10 [22%]) and cellulitis (n=6 [13%]).

203 re related to study treatment (infusion-site cellulitis [n=2], infusion-site abscess and infusion-sit

204 PR40, adverse events were more frequent, and cellulitis occurred (n = 6).

205 ss all groups, with only new skin ulcers and cellulitis occurring in more than 5% of patients.

206 ynecological infections (mastitis and pelvic cellulitis) occurring in the French national cohort of w

207 Diagnosis of orbital cellulitis of dental origin was determined on the basis

208 During his hospitalization, he developed cellulitis of the left hand and persistent bacteremia wi

209 Cellulitis of the leg is a common bacterial infection of

210 olving patients with two or more episodes of cellulitis of the leg who were recruited in 28 hospitals

211 In patients with recurrent cellulitis of the leg, penicillin was effective in preve

212 ly treated osteomyelitis, and 1 patient with cellulitis of the thumb.

213 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous conditi

214 valence of retinoblastoma-associated orbital cellulitis on MRI was calculated.

215 otting of a fistula (two patients), chemical cellulitis (one patient), and increased serum creatinine

216 site cellulitis [one [1%]] and infusion site cellulitis [one [1%]).

217 s infections and infestations (catheter site cellulitis [one [1%]] and infusion site cellulitis [one

218 There were 2 cases of periorbital cellulitis, one in each treatment group.

219 acterial skin and skin-structure infections (cellulitis or erysipelas, major cutaneous abscess, or wo

220 in structure infections (ABSSSIs), including cellulitis or erysipelas, major cutaneous abscesses, and

221 ified by type of infection (wound infection, cellulitis or erysipelas, or major abscess) and receipt

222 pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or

223 ons, 101 had possible, probable, or definite cellulitis or soft tissue infections.

224 = 2.9; CI, 1.6-5.3; P < .0001), skin abscess/cellulitis (OR = 1.75; CI, 1.1-2.8; P = .02), pyogenic a

225 was twice as likely to have lymphangitis or cellulitis (OR = 2.02, P = .009).

226 ls in the past, and was mislabeled as either cellulitis, or congenital hemihyperplasia.

227 t organisms, secondary conditions that mimic cellulitis, or underlying complicating conditions such a

228 ontraumatic intracranial hemorrhage, orbital cellulitis, osteomyelitis, ovarian torsion, pulmonary em

229 ypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cas

230 code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia.

231 ass index, shorter duration of symptoms, and cellulitis other than typical erysipelas were predictors

232 tive complications (eg, quinsy, impetigo and cellulitis, otitis media, and sinusitis) or reconsultati

233 onal lymph node irradiation (P = .0364), and cellulitis (P < .001).

234 The implementation of the Auckland cellulitis pathway, readily generalizable to other setti

235 Patients with cellulitis patients are seldom admitted to the ICU.

236 Cellulitis patients had an average maximum affected skin

237 re differences between sites were greater in cellulitis patients than in pseudocellulitis patients (3

238 part, to lack of experimental evidence among cellulitis patients.

239 mplications of otitis media, including local cellulitis, perichondritis, mastoiditis, and intracrania

240 ge of invasive disease episodes (erysipelas, cellulitis, pneumonia, bacteremia, septic arthritis, str

241 ve leg compression therapy plus education on cellulitis prevention (compression group) or education a

242 Secondary outcomes included cellulitis-related hospital admission and quality-of-lif

243 Periocular cellulitis remains an important and common entity in oph

244 is of several skin diseases, but its role in cellulitis remains unknown.

245 r, clinical characteristics of patients with cellulitis requiring intensive care treatment are poorly

246 Relative to asthma and cellulitis, respiratory infection was associated with a

247 ithout metastasis), infection (pneumonia and cellulitis), response (tachypnea, bandemia, and tachycar

248 lation level, admissions to the hospital for cellulitis risk are strongly associated with warmer weat

249 Patients admitted with asthma or cellulitis served as comparators.

250 The Dundee classification of cellulitis severity, previously shown to predict disease

251 Treatment of uncomplicated cellulitis should be directed against Streptococcus and

252 Treatment of primary and recurrent cellulitis should initially cover Streptococcus and meth

253 Retinoblastoma cases presenting with orbital cellulitis show MRI findings of a larger eye size, exten

254 Retinoblastoma with orbital cellulitis showed significantly more tumor necrosis, uve

255 steomyelitis (nine), septic arthritis (one), cellulitis (six)], vascular system [18; septic thromboph

256 rrow signal intensity) and secondary (ulcer, cellulitis, soft-tissue mass, abscess, sinus tract, cort

257 tigated the skin microbiota in patients with cellulitis, studied whether its analysis could help dete

258 d two minor procedure-related complications (cellulitis, sympathetic dystrophy).

259 ho presented with hydrocephalus, necrotizing cellulitis, systemic inflammation, and respiratory failu

260 a higher clinical cure rate of uncomplicated cellulitis than cephalexin alone.

261 sulted in a lower incidence of recurrence of cellulitis than conservative treatment.

262 In pediatric orbital cellulitis, the likelihood of surgical intervention can

263 In these 15 patients with MRSA orbital cellulitis, the typical clinical setting of orbital cell

264 Among patients with uncomplicated cellulitis, the use of cephalexin plus trimethoprim-sulf

265 llin-resistant S. aureus or S. pyogenes from cellulitis tissue specimens.

266 (95% CI 1.83-2.19; p < 0.001) for cutaneous cellulitis to 5.84 (95% CI 5.61-6.08; p < 0.001) for low

267 ported events (all treatments combined) were cellulitis (two cases), pulmonary embolus (two cases), a

268 e, 13-55 years), who had odontogenic orbital cellulitis underwent clinical evaluation, CT scanning, a

269 Rates of cellulitis, use of lymphedema-related manual therapy, ou

270 abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-

271 th of ICU stay was shorter for patients with cellulitis vs patients with necrotizing fasciitis (3 [2-

272 Cellulitis vs pseudocellulitis was assessed by a 6-physi

273 ature of the affected limb for patients with cellulitis was 33.2 degrees C compared with 31.2 degrees

274 valence of retinoblastoma-associated orbital cellulitis was 6.8% (16/236).

275 The median time to a first recurrence of cellulitis was 626 days in the penicillin group and 532

276 tis, the typical clinical setting of orbital cellulitis was absent; chiefly, there was no identified

277 Orbital cellulitis was considered as a differential diagnosis in

278 ta composition of patients hospitalized with cellulitis was observed.

279 Retrospective review identified severe cellulitis was the reason for ICU admission in 23 patien

280 kin microbiota in patients hospitalized with cellulitis, we were unable to identify a typical celluli

281 ents who were discharged with a diagnosis of cellulitis were categorized as having cellulitis, while

282 uently, 30 retinoblastoma cases with orbital cellulitis were compared with 30 matched retinoblastoma

283 ment of a large urban hospital with presumed cellulitis were enrolled.

284 Patients with cellulitis were found to be less severely ill than patie

285 ofilms in chronic rhinosinusitis and orbital cellulitis were not elucidated earlier.

286 tients (age range, 11-59 years) with orbital cellulitis were studied.

287 dicated by synovial enhancement and adjacent cellulitis) were evaluated by two musculoskeletal radiol

288 Adverse events, including cellulitis, were more frequent with APR40, which was dis

289 RSA coverage for cellulitis, except purulent cellulitis, which is uncommon.

290 patients to establish a predictive model for cellulitis, which was then validated in the other cohort

291 sis of cellulitis were categorized as having cellulitis, while those who were given an alternative di

292 (100%) in the control group were treated for cellulitis with antibiotics vs 2 patients (10%) in the t

293 with acute onset (within 14 days) of orbital cellulitis with or without abscess.

294 ere available for the infection (impetigo or cellulitis with purulent drainage but no abscess), there

295 tive of right-sided pansinusitis and orbital cellulitis with right superior ophthalmic vein thrombosi

296 necrotizing fasciitis, septic shock, or GAS cellulitis with shock) were identified.

297 Among patients diagnosed with cellulitis without abscess, the addition of trimethoprim

298 We conducted a study of adults with acute cellulitis without drainage presenting to a US emergency

299 For cellulitis without purulent drainage, beta-hemolytic str

300 ning from a fishing trip and was treated for cellulitis without success.